Does MEPOLIZUMAB Cause Performance status decreased? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Performance status decreased have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.0% of all adverse event reports for MEPOLIZUMAB.
15
Reports of Performance status decreased with MEPOLIZUMAB
0.0%
of all MEPOLIZUMAB reports
1
Deaths
10
Hospitalizations
How Dangerous Is Performance status decreased From MEPOLIZUMAB?
Of the 15 reports, 1 (6.7%) resulted in death, 10 (66.7%) required hospitalization.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
LUMATEPERONE (68)
Which MEPOLIZUMAB Alternatives Have Lower Performance status decreased Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE